5NX.F NEXSTIM OYJ

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
8.67 EUR
Close of Nov 11, 2026
7.94 14.70
Market cap
EUR 62.7M
P/E
-
P/B
7.32x
ROE
13.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 5NX.F undervalued?

Graham number

The Graham number of NEXSTIM OYJ cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NEXSTIM OYJ fundamental analysis

No fundamental analysis for NEXSTIM OYJ yet.

NEXSTIM OYJ stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NEXSTIM OYJ

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company offers non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS), including Navigated Brain Stimulation (NBS) system 6 for presurgical mapping of the speech and motor cortices of the brain, for the treatment of major depression and chronic unilate…

Full company profile